{"a":[{"_":"Chutes & Ladders—Legend poaches Novartis vet to boost commercial potential","$":{"href":"/biotech/chutes-ladders-legend-poaches-novartis-vet-boost-commercial-potential","hreflang":"en"}}]}

Summary

Legend Biotech has appointed Ingrid Zhang, a Novartis veteran, as its new permanent CEO following the departure of former CEO Ying Huang in July. The move aims to strengthen the CAR-T specialist's commercial potential as it enters its next growth phase.